innovation for industry
Article | Micro-nanoelectronics
A unique interface between patients and the medical industry
Hub4aim has an unique proposal to manage the preindustrial
phase from the proof of concept to regulatory marking.
A new diagnostic technology could help confirm heart attacks faster and more cost-effectively than conventional antibody screening. Proof-of-concept testing was completed successfully on blood-clotting enzyme thrombin, which means that the technology could potentially be used to detect troponin, a cardiovascular disease biomarker. The goal is to improve patient care through faster, more affordable testing.
Leti, a CEA Tech institute, has developed non-cooled spectrometric detector that can clearly distinguish breast tumor tissue from healthy tissue in mice at a glance.
In a world first, a CEA-Leti team has produced a magnetoencephalography (MEG) prototype operating at room temperature that can produce brain images comparable with those generated by current equipment running at temperatures close to absolute zero. This quantum technology could expand access to MEG systems, help create highly miniaturized MEG systems and diversify their use. A start-up, MAG4Health, has recently been launched.
Leti, a CEA Tech institute, is coordinating the development of ISO standards for microfluidics. The goal is to speed up research and development in a field where design rules are often proprietary and empirical.
The Clinatec endowment fund has earned the support of several patrons, including the Covea mutual insurance company, since 2020.
Nano-biotechnology PlatformClinatec Platform
Connected Health ＆ WellnessAgriculture, Food Industry ＆ Environment
Smart Medical Technologies
See all demos
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.